Related references
Note: Only part of the references are listed.Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance
S. Ramadoss et al.
ONCOGENE (2017)
Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine
Mikkel Staberg et al.
CELLULAR ONCOLOGY (2017)
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
Martin J. van den Bent et al.
LANCET (2017)
Transcription elongation factors represent in vivo cancer dependencies in glioblastoma
Tyler E. Miller et al.
NATURE (2017)
Lomustine and Bevacizumab in Progressive Glioblastoma
Wolfgang Wick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL
Ibrahim Cagri Kurt et al.
CELL DEATH & DISEASE (2017)
Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma
M. A. Qazi et al.
ANNALS OF ONCOLOGY (2017)
Impact of H3K27 Demethylase Inhibitor GSKJ4 on NSCLC Cells Alone and in Combination with Metformin
Hikaru Watarai et al.
ANTICANCER RESEARCH (2016)
Histone demethylase KDM2B regulates lineage commitment in normal and malignant hematopoiesis
Jaclyn Andricovich et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Cancer stem cells: understanding tumor hierarchy and heterogeneity
Jeremy N. Rich
MEDICINE (2016)
An epigenetic gateway to brain tumor cell identity
Stephen C. Mack et al.
NATURE NEUROSCIENCE (2016)
Fbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2
Takeshi Ueda et al.
BLOOD (2015)
The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma
Barbara Banelli et al.
CELL CYCLE (2015)
Advances in the development of histone lysine demethylase inhibitors
Tamara Maes et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation
Yuhui Jiang et al.
NATURE CELL BIOLOGY (2015)
Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastoma
Stefano Amente et al.
ONCOTARGET (2015)
The FBXL10/KDM2B Scaffolding Protein Associates with Novel Polycomb Repressive Complex-1 to Regulate Adipogenesis
Takeshi Inagaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21
Bin Dai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
NDY1/KDM2B Functions as a Master Regulator of Polycomb Complexes and Controls Self-Renewal of Breast Cancer Stem Cells
Filippos Kottakis et al.
CANCER RESEARCH (2014)
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
Walter Taal et al.
LANCET ONCOLOGY (2014)
Inhibition of demethylases by GSK-J1/J4
Bo Heinemann et al.
NATURE (2014)
Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma
Rintaro Hashizume et al.
NATURE MEDICINE (2014)
The KDM2B-Let-7b-EZH2 Axis in Myelodysplastic Syndromes as a Target for Combined Epigenetic Therapy
Ekapun Karoopongse et al.
PLOS ONE (2014)
The histone LSD1 demethylase in stemness and cancer transcription programs
Stefano Amente et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2013)
Chromatin Remodeling at DNA Double-Strand Breaks
Brendan D. Price et al.
CELL (2013)
KDM4A Lysine Demethylase Induces Site-Specific Copy Gain and Rereplication of Regions Amplified in Tumors
Joshua C. Black et al.
CELL (2013)
Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes
Jin He et al.
NATURE CELL BIOLOGY (2013)
Histone lysine demethylases as targets for anticancer therapy
Jonas W. Hojfeldt et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Histone Demethylase KDM5B Collaborates with TFAP2C and Myc To Repress the Cell Cycle Inhibitor p21cip (CDKN1A)
Ping-Pui Wong et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact
Joshua C. Black et al.
MOLECULAR CELL (2012)
The role of histone demethylases in cancer therapy
Inga Hoffmann et al.
MOLECULAR ONCOLOGY (2012)
Kdm2b promotes induced pluripotent stem cell generation by facilitating gene activation early in reprogramming
Gaoyang Liang et al.
NATURE CELL BIOLOGY (2012)
KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands
Anca M. Farcas et al.
ELIFE (2012)
KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia
Jin He et al.
BLOOD (2011)
Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers
Shinya Hayami et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Lysine-specific Demethylase 2B (KDM2B)-let-7-Enhancer of Zester Homolog 2 (EZH2) Pathway Regulates Cell Cycle Progression and Senescence in Primary Cells
Alexandros Tzatsos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
BMI1 Is Recruited to DNA Breaks and Contributes to DNA Damage-Induced H2A Ubiquitination and Repair
Vasudeva Ginjala et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
Histone demethylases in development and disease
Marianne Terndrup Pedersen et al.
TRENDS IN CELL BIOLOGY (2010)
EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
Mario-Luca Suva et al.
CANCER RESEARCH (2009)
ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
Yifang Hu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus
Alexandros Tzatsos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15Ink4b
Jin He et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
DNA damage signalling guards against activated oncogenes and tumour progression
J. Bartek et al.
ONCOGENE (2007)
被撤回的出版物: shRNA knockdown of Bmi-1 reveals a critical role for p21-rb pathway in NSC self-renewal during development (Retracted article. See vol. 30, pg. 904, 2023)
Christopher A. Fasano et al.
CELL STEM CELL (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
J Bartkova et al.
NATURE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Role of polycomb group proteins in stem cell self-renewal and cancer
J Gil et al.
DNA AND CELL BIOLOGY (2005)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Share Paper
